Primary Prevention of Allergic Disease in Early Child by Lactobacillus Reuteri

计划入组 232 人 · 首次发布于 2011 年 1 月 28 日

Efficacy and Safety of LAIS® Mites Sublingual Tablets

计划入组 45 人 · 首次发布于 2014 年 10 月 29 日

3TR Asthma Biologics Cohort (ABC) Study

计划入组 600 人 · 首次发布于 2023 年 11 月 13 日

Alimemazine(Panectyl)

C₁₈H₂₂N₂S

extracellular vesicle therapy (orthopedic conditions)

Medrysone(Hms)

C₂₂H₃₂O₃

Gossamer Bio

United States

Xencor

United States

Third Harmonic Bio

United States

Xolair Evaluated for Asthma Prevention in High-Risk Young Children

Revolo Bio's '1104 Shows Promise in Resetting Immune Response in Allergic Diseases

Inimmune Launches Pivotal Phase 2 Trial of INI-2004 for Allergic Rhinitis Treatment